EUVIMEDEUVIMED entdecken
Open Access

Single-Cell Transcriptomic Profiling Reveals KRAS/TP53-Driven Neutrophil Reprogramming in Luad: A Multi-Gene Prognostic Model and Therapeutic Targeting of RHOV

Yinghui Ye, Yulou Luo, Yutian Sun, Yujie Zhang, Jiaxin Lin, Ziling Yang, Anping Xu, Bei Xue

Oncology Research · 2025

DOI: 10.32604/or.2025.062584 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Research, 2025. Verfasst von Yinghui Ye und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Xinhua Hospital, Shenzhen, 518000, China. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins p21(ras), Neutrophils, Tumor Suppressor Protein p53, Lung Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene Proteins p21(ras)NeutrophilsTumor Suppressor Protein p53Lung NeoplasmsAdenocarcinoma of LungHumansPrognosisGene Expression ProfilingSingle-Cell AnalysisTumor MicroenvironmentMutationProto-Oncogene MasTranscriptomeBiomarkers, TumorCell Line, TumorGene Expression Regulation, NeoplasticFemaleMale

Stichwörter der Autor:innen

KRAS/TP53 mutationsLung adenocarcinoma (LUAD)neutrophilprognosissingle-cell analysistumor microenvironment

Substanzen

Proto-Oncogene Proteins p21(ras)KRAS protein, humanTumor Suppressor Protein p53TP53 protein, humanMAS1 protein, humanProto-Oncogene MasBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Laboratory Medicine, Xinhua Hospital, Shenzhen, 518000, China.
  • Department of Breast Surgery, Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi, 830000, China.
  • Department of Medical Oncology, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, 610000, China.
  • National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, 518000, China.
  • Medical College, Shantou University, Shantou, 515000, China.
  • Department of Laboratory Medicine, Shenzhen Hospital, Peking University, Shenzhen, 518000, China.

Zitieren

APA

Ye, Y., Luo, Y., Sun, Y., Zhang, Y., Lin, J., Yang, Z., Xu, A., & Xue, B. (2025). Single-Cell Transcriptomic Profiling Reveals KRAS/TP53-Driven Neutrophil Reprogramming in Luad: A Multi-Gene Prognostic Model and Therapeutic Targeting of RHOV. Oncology Research. https://doi.org/10.32604/or.2025.062584

Vancouver

Ye Y, Luo Y, Sun Y, Zhang Y, Lin J, Yang Z, et al. Single-Cell Transcriptomic Profiling Reveals KRAS/TP53-Driven Neutrophil Reprogramming in Luad: A Multi-Gene Prognostic Model and Therapeutic Targeting of RHOV. Oncology Research. 2025. doi:10.32604/or.2025.062584

BibTeX
@article{Ye2025,
  author = {Ye, Yinghui and Luo, Yulou and Sun, Yutian and Zhang, Yujie and Lin, Jiaxin and Yang, Ziling and Xu, Anping and Xue, Bei},
  title = {Single-Cell Transcriptomic Profiling Reveals KRAS/TP53-Driven Neutrophil Reprogramming in Luad: A Multi-Gene Prognostic Model and Therapeutic Targeting of RHOV},
  journal = {Oncology Research},
  year = {2025},
  doi = {10.32604/or.2025.062584}
}
Kostenlos starten →